bpc 157 oral dosage protocol 500mcg capsules BPC-157 benefits, dosage, and side effects Regeneration or Risk? A Narrative

10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats

Therapeutic claims are not recognized by regulatory authorities

Source Quality BPC-157 isn't FDA-approved as a therapeutic drug

Combination-Protocol Research Beyond the individual studies referenced above, several published research lines have specifically investigated BPC-157 and TB-500 in combination : Combined BPC-157 + TB-500 in musculoskeletal injury models searches across rodent rotator-cuff, Achilles tendon and ligament transection research